Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to 0.81.

  • Ocular Therapeutix's Equity Ratio rose 1758.74% to 0.81 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.81, marking a year-over-year increase of 1758.74%. This contributed to the annual value of 0.81 for FY2025, which is 1758.74% up from last year.
  • As of Q4 2025, Ocular Therapeutix's Equity Ratio stood at 0.81, which was up 1758.74% from 0.63 recorded in Q3 2025.
  • Over the past 5 years, Ocular Therapeutix's Equity Ratio peaked at 0.81 during Q4 2025, and registered a low of 0.03 during Q2 2023.
  • Over the past 5 years, Ocular Therapeutix's median Equity Ratio value was 0.41 (recorded in 2021), while the average stood at 0.45.
  • In the last 5 years, Ocular Therapeutix's Equity Ratio crashed by 9337.52% in 2023 and then skyrocketed by 279987.51% in 2024.
  • Over the past 5 years, Ocular Therapeutix's Equity Ratio (Quarter) stood at 0.43 in 2021, then crashed by 44.82% to 0.24 in 2022, then surged by 52.56% to 0.36 in 2023, then soared by 90.47% to 0.69 in 2024, then increased by 17.59% to 0.81 in 2025.
  • Its Equity Ratio was 0.81 in Q4 2025, compared to 0.63 in Q3 2025 and 0.68 in Q2 2025.